Neurochemistry

The study of the molecular mechanisms underlying the development of type 1 and type 2 diabetes mellitus (DM) and metabolic syndrome and their complications from the nervous and endocrine systems, as well as the development of new approaches for their timely diagnosis and treatment.

The Embryophysiology Group is investigating the mechanisms by which neurotransmitters regulate the early stages of embryonic development and oogenesis. The team studies the interaction of neurotransmitters with other signaling pathways and factors to determine how these substances coordinate and tune the processes of embryogenesis. The results of these studies help us better understand the activity of neurotransmitters in the early stages of development and assess their importance for the normal development of the body.

Investigation of functional and biochemical mechanisms of brain plasticity. The role of apoptotic mechanisms in the functioning of cells of the nervous system in normal and pathological conditions. The role of nitric oxide and its synthesis systems in the brain in normal and pathological conditions. The study of the functional and biochemical mechanisms of GNI pathologies and the development of pathogenetically directed ways to correct them. Investigation of the role of exosomes in the development of diseases of the nervous system.

We are engaged in the study of attention, memory and neuropathology of epilepsy, Alzheimer's disease and Parkinson's disease. Our research is aimed at understanding the connection between the levels of brain organization: from molecules to interstructural relationships.